Old | New | Differences | |
---|---|---|---|
1 | - | An Act | |
2 | - | ENROLLED HOUSE | |
1 | + | ||
2 | + | ||
3 | + | SENATE FLOOR VERSION - HB3574 SFLR Page 1 | |
4 | + | (Bold face denotes Committee Amendments) 1 | |
5 | + | 2 | |
6 | + | 3 | |
7 | + | 4 | |
8 | + | 5 | |
9 | + | 6 | |
10 | + | 7 | |
11 | + | 8 | |
12 | + | 9 | |
13 | + | 10 | |
14 | + | 11 | |
15 | + | 12 | |
16 | + | 13 | |
17 | + | 14 | |
18 | + | 15 | |
19 | + | 16 | |
20 | + | 17 | |
21 | + | 18 | |
22 | + | 19 | |
23 | + | 20 | |
24 | + | 21 | |
25 | + | 22 | |
26 | + | 23 | |
27 | + | 24 | |
28 | + | ||
29 | + | SENATE FLOOR VERSION | |
30 | + | April 11, 2024 | |
31 | + | ||
32 | + | ||
33 | + | ENGROSSED HOUSE | |
3 | 34 | BILL NO. 3574 By: Pae of the House | |
4 | 35 | ||
5 | 36 | and | |
6 | 37 | ||
7 | 38 | Prieto of the Senate | |
8 | - | ||
9 | - | ||
10 | 39 | ||
11 | 40 | ||
12 | 41 | ||
13 | 42 | ||
14 | 43 | An Act relating to public health and safety; amending | |
15 | 44 | 63 O.S. 2021, Sections 1 -1432.2 and 1-1432.4, which | |
16 | 45 | relate to the Oklahoma Kr atom Consumer Protection | |
17 | 46 | Act; adding and modifying definitions; providing | |
18 | 47 | restrictions on the preparation, distribution, or | |
19 | 48 | sale of certain kratom products; and providing an | |
20 | 49 | effective date. | |
21 | 50 | ||
22 | 51 | ||
23 | 52 | ||
24 | - | ||
25 | - | SUBJECT: Public health and safe ty | |
26 | - | ||
27 | 53 | BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: | |
28 | - | ||
29 | 54 | SECTION 1. AMENDATORY 63 O.S. 2021, Section 1 -1432.2, is | |
30 | 55 | amended to read as follows: | |
31 | - | ||
32 | 56 | Section 1-1432.2 As used in this act: | |
33 | - | ||
34 | 57 | 1. "Food" means a food, food product, food ingredient, dietary | |
35 | 58 | ingredient, dietary supplement or beverage for huma n consumption; | |
36 | - | ||
37 | 59 | 2. "Kratom leaf" means the leaf of the kratom plant, Mitragyna | |
38 | 60 | speciosa, in fresh or dehydrated or dried form that undergoes no | |
39 | 61 | post-harvest processing other than drying or size reduction by | |
40 | 62 | cutting, milling, or similar procedure, and may b e cleaned or | |
41 | 63 | sterilized using standard treatments applied to food ingredients, | |
42 | 64 | such as heat, steam, pressurization, or irradiation or other | |
65 | + | ||
66 | + | SENATE FLOOR VERSION - HB3574 SFLR Page 2 | |
67 | + | (Bold face denotes Committee Amendments) 1 | |
68 | + | 2 | |
69 | + | 3 | |
70 | + | 4 | |
71 | + | 5 | |
72 | + | 6 | |
73 | + | 7 | |
74 | + | 8 | |
75 | + | 9 | |
76 | + | 10 | |
77 | + | 11 | |
78 | + | 12 | |
79 | + | 13 | |
80 | + | 14 | |
81 | + | 15 | |
82 | + | 16 | |
83 | + | 17 | |
84 | + | 18 | |
85 | + | 19 | |
86 | + | 20 | |
87 | + | 21 | |
88 | + | 22 | |
89 | + | 23 | |
90 | + | 24 | |
91 | + | ||
43 | 92 | standard treatments applied to food ingredients. The total alkaloid | |
44 | 93 | content of kratom leaf material used in the kra tom product shall not | |
45 | 94 | exceed three and one -half percent (3.5%) measured on a dried weight - | |
46 | - | to-weight basis; ENR. H. B. NO. 3574 Page 2 | |
47 | - | ||
95 | + | to-weight basis; | |
48 | 96 | 3. "Kratom leaf extract" means the material obtained by | |
49 | 97 | extracting kratom using a solvent consisting of: | |
50 | - | ||
51 | 98 | a. water, ethanol, or food -grade carbon dioxide (CO2), or | |
52 | - | ||
53 | 99 | b. any other solvent allowed by federal or state | |
54 | 100 | regulation for use in manufacturing a food ingredient. | |
55 | - | ||
56 | 101 | The extracted material shall contain mitragynine as the most | |
57 | 102 | abundant alkaloid, measured on a weight -to-weight basis, and at a | |
58 | 103 | level that is equal to or exceeds twice that of any other alkaloid | |
59 | 104 | present. The ratio of mitragynine to other alkaloids in the extract | |
60 | 105 | shall be equal to or greater than the ratio found in the starti ng | |
61 | 106 | material; | |
62 | - | ||
63 | 107 | 4. "Kratom product" means a food product or ingredient | |
64 | 108 | containing any part of the dietary supplement that consists of or | |
65 | 109 | contains kratom leaf of the plant Mitragyna speciosa or kratom leaf | |
66 | 110 | extract that does not contain any synthesized kratom alkaloids, | |
67 | 111 | other kratom constituents, or synthesized metabolites o f any kratom | |
68 | 112 | constituent in which the level of 7 -hydroxymitragynine, on a percent | |
69 | 113 | weight basis, is not greater than one percent (1%) of the amount of | |
70 | 114 | total kratom alkaloids, as confirmed wi th a high-performance liquid | |
71 | 115 | chromatography testing method. For pu rposes of this paragraph, | |
116 | + | ||
117 | + | SENATE FLOOR VERSION - HB3574 SFLR Page 3 | |
118 | + | (Bold face denotes Committee Amendments) 1 | |
119 | + | 2 | |
120 | + | 3 | |
121 | + | 4 | |
122 | + | 5 | |
123 | + | 6 | |
124 | + | 7 | |
125 | + | 8 | |
126 | + | 9 | |
127 | + | 10 | |
128 | + | 11 | |
129 | + | 12 | |
130 | + | 13 | |
131 | + | 14 | |
132 | + | 15 | |
133 | + | 16 | |
134 | + | 17 | |
135 | + | 18 | |
136 | + | 19 | |
137 | + | 20 | |
138 | + | 21 | |
139 | + | 22 | |
140 | + | 23 | |
141 | + | 24 | |
142 | + | ||
72 | 143 | "synthesized" refers to substances produced using directed synthetic | |
73 | 144 | or biosynthetic chemistry, as opposed to traditional food | |
74 | 145 | preparation techniques such as heating or extracting ; and | |
75 | - | ||
76 | 146 | 3. 5. "Total kratom alkaloids" means the sum of mitragynine, | |
77 | 147 | speciociliatine, speciogynine, paynantheine, and 7 - | |
78 | 148 | hydroxymitragynine; and | |
79 | - | ||
80 | 149 | 6. "Vendor" means a person that sells, prepares or maintains | |
81 | 150 | kratom products or that advertises, represents or holds itself out | |
82 | 151 | as selling, preparing or maintainin g kratom products and includes a | |
83 | 152 | manufacturer, wholesaler, store, restaurant, hotel, catering | |
84 | 153 | facility, camp, bakery, delicatessen, supermarket, grocery store, | |
85 | 154 | convenience store, nursing home or food or drink company. | |
86 | - | ||
87 | 155 | SECTION 2. AMENDATORY 63 O.S. 2021, Section 1 -1432.4, is | |
88 | 156 | amended to read as follows: | |
89 | - | ||
90 | 157 | Section 1-1432.4 A. A vendor shall not prepare, distribute, | |
91 | - | sell or expose for sale any of the f ollowing: ENR. H. B. NO. 3574 Page 3 | |
92 | - | ||
158 | + | sell or expose for sale any of the following: | |
93 | 159 | 1. A kratom product that is adulterated with a nonkratom | |
94 | 160 | substance. A does not meet the definition for a kratom product is | |
95 | 161 | adulterated with a nonkratom substance if the kratom product is | |
96 | 162 | mixed or packed with a nonkratom substance and that substance | |
97 | 163 | affects the quality or strength of the kratom product to such a | |
98 | 164 | degree as to render the kratom product injurious to a consumer | |
99 | 165 | pursuant to Section 1 -1432.2 of this title ; | |
100 | 166 | ||
167 | + | SENATE FLOOR VERSION - HB3574 SFLR Page 4 | |
168 | + | (Bold face denotes Committee Amendments) 1 | |
169 | + | 2 | |
170 | + | 3 | |
171 | + | 4 | |
172 | + | 5 | |
173 | + | 6 | |
174 | + | 7 | |
175 | + | 8 | |
176 | + | 9 | |
177 | + | 10 | |
178 | + | 11 | |
179 | + | 12 | |
180 | + | 13 | |
181 | + | 14 | |
182 | + | 15 | |
183 | + | 16 | |
184 | + | 17 | |
185 | + | 18 | |
186 | + | 19 | |
187 | + | 20 | |
188 | + | 21 | |
189 | + | 22 | |
190 | + | 23 | |
191 | + | 24 | |
192 | + | ||
101 | 193 | 2. A kratom product that is contaminated with a dangerous | |
102 | 194 | nonkratom substance. A kratom product is contaminated with a | |
103 | 195 | dangerous nonkratom substance if the kratom product contains a | |
104 | 196 | substance that is not safe for human consumption; | |
105 | - | ||
106 | 197 | 3. A kratom product containing a level of 7 -hydroxymitragynine | |
107 | 198 | in the alkaloid fraction that is greater than two one percent (2%) | |
108 | 199 | (1%) of the alkaloid composition of the product; | |
109 | - | ||
110 | 200 | 4. A kratom product containing any synthetic synthesized | |
111 | 201 | alkaloid including synthetic synthesized mitragynine, synthetic | |
112 | 202 | synthesized 7-hydroxymitragynine or any other synthetically derived | |
113 | 203 | synthesized compounds of the kratom plant; or | |
114 | - | ||
115 | 204 | 5. A kratom product contai ning any controlled substance listed | |
116 | 205 | in the Uniform Controlled Dangerous Substances Act, unless the | |
117 | 206 | product is compounded by a licensed pharmacist with the controlled | |
118 | 207 | substance dispensed in accordance with a valid prescription ; or | |
119 | - | ||
120 | 208 | 6. A kratom product cont aining a level of any residual solvent | |
121 | 209 | that was used in the manufacturing of the extract that exceeds the | |
122 | 210 | residual level specified for pharmaceutical products in the document | |
123 | 211 | "Q3C - Tables and List, Guidance for Industry, [June 2017] ICH | |
124 | 212 | Revision 3" issued by the United States Department of Health and | |
125 | 213 | Human Services, Food and Drug Administration . | |
126 | - | ||
127 | 214 | B. Kratom products shall be accompanied by a label , or a quick | |
128 | 215 | response (QR) code on the product label linked to a website, bearing | |
129 | 216 | the following information prio r to its sale in this state: | |
130 | 217 | ||
218 | + | SENATE FLOOR VERSION - HB3574 SFLR Page 5 | |
219 | + | (Bold face denotes Committee Amendments) 1 | |
220 | + | 2 | |
221 | + | 3 | |
222 | + | 4 | |
223 | + | 5 | |
224 | + | 6 | |
225 | + | 7 | |
226 | + | 8 | |
227 | + | 9 | |
228 | + | 10 | |
229 | + | 11 | |
230 | + | 12 | |
231 | + | 13 | |
232 | + | 14 | |
233 | + | 15 | |
234 | + | 16 | |
235 | + | 17 | |
236 | + | 18 | |
237 | + | 19 | |
238 | + | 20 | |
239 | + | 21 | |
240 | + | 22 | |
241 | + | 23 | |
242 | + | 24 | |
243 | + | ||
131 | 244 | 1. A list of the ingredients, which shall include the common or | |
132 | 245 | usual name of each ingredient used in the manufacture of the | |
133 | 246 | product, listed in descending orde r of predominance; | |
134 | - | ||
135 | 247 | 2. That the sale or transfer of kratom to a per son under | |
136 | - | eighteen (18) years of age is prohi bited; ENR. H. B. NO. 3574 Page 4 | |
137 | - | ||
248 | + | eighteen (18) years of age is prohibited; | |
138 | 249 | 3. The amount of total kratom alkaloids, mitragynine, and 7- | |
139 | 250 | hydroxymitragynine contained in the product; | |
140 | - | ||
141 | 251 | 4. The amount of total kratom alkaloids, mitragynine, and 7- | |
142 | 252 | hydroxymitragynine contained in packa ging for the product; | |
143 | - | ||
144 | 253 | 5. The name and the principal street address of the vendor or | |
145 | 254 | the person responsible for distributing the product; | |
146 | - | ||
147 | 255 | 6. The suggested Any federal food allergen labelin g | |
148 | 256 | requirements, if applicable, and clear and adequate directions fo r | |
149 | 257 | the consumption and safe and effective use of the such product, | |
150 | 258 | including the recommended serving size, the number of servings in | |
151 | 259 | the container, and the number of servings that can be safely | |
152 | 260 | consumed in a day. Provided, liquid kratom products shall be | |
153 | 261 | packaged in a retail container that has clear serving size markings | |
154 | 262 | and be subject to the following requirements: | |
155 | - | ||
156 | 263 | a. products of less than eight (8) fluid ounces which | |
157 | 264 | contain more than thre e servings shall be accompanied | |
158 | 265 | by a calibrated measuring device, a nd | |
159 | 266 | ||
267 | + | SENATE FLOOR VERSION - HB3574 SFLR Page 6 | |
268 | + | (Bold face denotes Committee Amendments) 1 | |
269 | + | 2 | |
270 | + | 3 | |
271 | + | 4 | |
272 | + | 5 | |
273 | + | 6 | |
274 | + | 7 | |
275 | + | 8 | |
276 | + | 9 | |
277 | + | 10 | |
278 | + | 11 | |
279 | + | 12 | |
280 | + | 13 | |
281 | + | 14 | |
282 | + | 15 | |
283 | + | 16 | |
284 | + | 17 | |
285 | + | 18 | |
286 | + | 19 | |
287 | + | 20 | |
288 | + | 21 | |
289 | + | 22 | |
290 | + | 23 | |
291 | + | 24 | |
292 | + | ||
160 | 293 | b. if such a product contains more than the eight (8) | |
161 | 294 | fluid ounces, the requirements specified in | |
162 | 295 | subparagraph a of this paragraph do not apply. | |
163 | - | ||
164 | 296 | Provided further, packaging for powdered kratom products not in | |
165 | 297 | capsule form shall have a calibrated measur ing device included in | |
166 | 298 | the container; and | |
167 | - | ||
168 | 299 | 7. Any precautionary statements as to the safety and | |
169 | 300 | effectiveness of the product , including a warning that a consumer | |
170 | 301 | should consult a health care professional on questions about the use | |
171 | 302 | of kratom, that the produ ct may be habit-forming, and a statement | |
172 | 303 | that the kratom product is not intended to "diagnose, treat, cure, | |
173 | 304 | or prevent any disease"; and | |
174 | - | ||
175 | 305 | 8. A statement that a kratom product label is prohibited from | |
176 | 306 | making any therapeutic claims unless approved by the Uni ted States | |
177 | 307 | Food and Drug Administration . | |
178 | - | ||
179 | 308 | C. A vendor may not distribute, sell or expose for sale a | |
180 | 309 | kratom product to an individual under eighteen (18) years of age. | |
181 | - | ENR. H. B. NO. 3574 Page 5 | |
182 | 310 | D. Upon request by the State Department of Health, the vendor | |
183 | 311 | shall provide test results from a United States -based testing | |
184 | 312 | facility to confirm the items listed on the product label. | |
185 | - | ||
186 | 313 | SECTION 3. This act shall become effective November 1, 2024. | |
187 | - | ENR. H. B. NO. 3574 Page 6 | |
188 | - | Passed the House of Representati ves the 5th day of March, 2024. | |
189 | - | ||
190 | - | ||
191 | - | ||
192 | - | ||
193 | - | Presiding Officer of the House | |
194 | - | of Representatives | |
195 | - | ||
196 | - | ||
197 | - | ||
198 | - | Passed the Senate the 25th day of April, 2024. | |
199 | - | ||
200 | - | ||
201 | - | ||
202 | - | ||
203 | - | Presiding Officer of the Senate | |
204 | - | ||
205 | - | ||
206 | - | OFFICE OF THE GOVERNOR | |
207 | - | Received by the Office of the Governor this _________ ___________ | |
208 | - | day of ___________________, 20_______, at _______ o'clock _______ M. | |
209 | - | By: _________________________________ | |
210 | - | Approved by the Governor of the State of Oklahoma this _____ ____ | |
211 | - | day of ___________________, 20_______, at _______ o'clock _______ M. | |
212 | - | ||
213 | - | ||
214 | - | _________________________________ | |
215 | - | Governor of the State of Oklahoma | |
216 | - | ||
217 | - | OFFICE OF THE SECRETARY OF STATE | |
218 | - | Received by the Office of the Secretary of State this __________ | |
219 | - | day of ___________________, 20_______, at _______ o'clock _______ M. | |
220 | - | By: _________________________________ | |
221 | - | ||
314 | + | COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES | |
315 | + | April 11, 2024 - DO PASS |